Romano joins the company from her most recent post as finance chief at Vicarious Surgical, bringing deep-rooted expertise in medical technology and emerging public markets. Her previous leadership roles at Entero Therapeutics and Kiora Pharmaceuticals underscore a career built on navigating the complexities of high-growth surgical tech sectors.

This appointment follows a series of leadership adjustments at the firm. Milan Rao, who assumed the finance role earlier this January alongside global operations duties, succeeded Naveen Kuma Amar following his sudden departure for personal reasons. Based in the U.S., Romano is expected to play a crucial role in scaling the company’s financial infrastructure as it seeks FDA approval for its flagship robotic platform.